About Basilisk
Basilisk is a company based in Delft (Netherlands) founded in 2015. It operates as a Direct-to-Consumer (D2C) and B2B2C. Basilisk offers products and services including Basilisk Healing Agent, Basilisk Repair Mortar MR3, and Basilisk Liquid Repair System ER7. Basilisk operates in a competitive market with competitors including BioSapien and Mimicrete, among others.
- Headquarter Delft, Netherlands
-
Sectors
Real Estate & ConstructionChemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$68.69 K (USD), Grant
Mar 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Basilisk
Basilisk offers a comprehensive portfolio of products and services, including Basilisk Healing Agent, Basilisk Repair Mortar MR3, and Basilisk Liquid Repair System ER7.
Used to enable self-healing in new concrete mixes.
Applied for repairing cracks in existing concrete structures.
Utilized for sealing cracks in existing concrete constructions.
Funding Insights of Basilisk
Investors in Basilisk
Basilisk has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and SHIFT Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage impact investments are focused on Dutch companies.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Basilisk
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Basilisk
Investment portfolio details for Basilisk
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Basilisk
Detailed financials for Basilisk
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Basilisk Comparisons
Peer comparison for Basilisk
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Basilisk
Basilisk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioSapien and Mimicrete, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of 3D-printed chip for cancer indications
|
|
| Locked | Locked | Locked |
Self-healing concrete mixes are manufactured for construction durability.
|
Detailed competitors of Basilisk
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Basilisk
Complete news archive for Basilisk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Basilisk
Basilisk was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Basilisk is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Bart Woerd is the current CEO of Basilisk.
Basilisk is focused on the development and provision of bio-based self-healing concrete products. These solutions are designed to enhance the durability and waterproofing of concrete structures. The technology utilizes microorganisms to produce limestone, autonomously repairing cracks in both new and existing concrete constructions. Sectors served include construction and infrastructure, with products applicable to water treatment plants and roadways. Benefits include reduced maintenance costs, extended lifespan of structures, and a significant reduction in CO2 footprint by 30-50.
Basilisk offers Basilisk Healing Agent, Basilisk Repair Mortar MR3, and Basilisk Liquid Repair System ER7.
Basilisk has 2 investors. Key investors include European Union, and SHIFT Invest.